Regenxbio
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $21,214 | $24,197 | $22,295 | $15,622 |
Gross Profit | 14,896 | 11,810 | 7,665 | 7,159 |
EBITDA | -37,746 | -54,816 | -48,489 | -57,177 |
EBIT | -41,769 | -58,777 | -52,540 | -61,356 |
Net Income | -51,186 | -59,597 | -52,989 | -63,330 |
Net Change In Cash | 21,214 | 24,197 | 22,295 | 15,622 |
Free Cash Flow | -32,703 | -40,875 | -45,971 | -56,012 |
Cash | 57,526 | 56,617 | 57,765 | 112,975 |
Basic Shares | 50,871 | 50,800 | 50,601 | 45,733 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $83,328 | $90,242 | $112,724 | $470,347 |
Gross Profit | 49,761 | 53,029 | 58,179 | 418,514 |
EBITDA | -198,228 | -239,464 | -244,242 | 169,544 |
EBIT | -214,443 | -256,784 | -257,151 | 159,980 |
Net Income | -227,102 | -263,494 | -280,321 | 127,840 |
Net Change In Cash | 83,328 | 90,242 | 112,724 | 470,347 |
Cost of Revenue | 7,483 | |||
Free Cash Flow | -175,561 | -228,367 | -238,212 | 134,700 |
Cash | 57,526 | 34,522 | 96,952 | 345,209 |
Basic Shares | 49,509 | 43,734 | 43,152 | 43,913 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$1.01 |
2024-09-30 | -$1.17 |
2024-06-30 | -$1.05 |
2024-03-31 | -$1.33 |
